Discontinuation report BUPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 216017 |
| Drug Identification Number | 02504979 |
| Brand name | BUPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | BUPIVACAINE HYDROCHLORIDE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
| Strength(s) | 7.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | RETROBULBAR EPIDURAL |
| Packaging size | 10 VIALS |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-05-31 |
| Actual discontinuation date | |
| Remaining supply date | 2024-05-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Current inventory expires on May 31, 2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-01-15 | French | Compare |
| v1 | 2024-01-15 | English | Compare |
Showing 1 to 2 of 2